| Jeffrey L Yee, MD | |
|
619 19th Street South, Birmingham, AL 35233 | |
| (205) 934-6600 | |
| Not Available |
| Full Name | Jeffrey L Yee |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 619 19th Street South, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235146523 | NPI | - | NPPES |
| 009900355 | Medicaid | AL | |
| 180045077 | Other | AL | RAILROAD MEDICARE |
| H62442 | Other | AL | HEALTHSPRING OF ALABAMA |
| 051510216 | Other | AL | BLUE CROSS |
| 925498 | Other | AL | BLOCK VISION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 24227 (Alabama) | Primary |
| Entity Name | University Of Alabama Ophthalmology Services Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485999 PECOS PAC ID: 9234023417 Enrollment ID: O20040210000034 |
News Archive
NPR's Weekend Edition Sunday interviewed Virginia Attorney General Ken Cuccinelli about the state's challenge to the federal government's health law requiring people to purchase health insurance. Cuccinelli said a judge that refused to throw out his case "did not say it's unconstitutional. But he did say that this legislation goes farther than anything that has been held constitutional under the Commerce Clause and it goes farther than anything that has been held constitutional under the taxing power before.
Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Benitec Biopharma Limited, a clinical-stage biotechnology company developing innovative therapeutics based on its gene-silencing technology, DNA-directed RNA interference (ddRNAi), is pleased to announce it has initiated a new site for its ongoing Phase 1/2a TT-034 trial at the Methodist Health System Clinical Research Institute in Dallas, Texas.
A study has shown a potential link between pregnancy-related anxiety and how a baby's brains respond to sad speech.
University of Georgia research has provided new clues on surviving to be 100 years old, finding that how we feel about ourselves and our ability to adapt to an accumulation of challenging life experiences may be as or more important than health factors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey L Yee, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 731-9701 | Jeffrey L Yee, MD 619 19th Street South, Birmingham, AL 35233 Ph: (205) 934-6600 |
News Archive
NPR's Weekend Edition Sunday interviewed Virginia Attorney General Ken Cuccinelli about the state's challenge to the federal government's health law requiring people to purchase health insurance. Cuccinelli said a judge that refused to throw out his case "did not say it's unconstitutional. But he did say that this legislation goes farther than anything that has been held constitutional under the Commerce Clause and it goes farther than anything that has been held constitutional under the taxing power before.
Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.
Benitec Biopharma Limited, a clinical-stage biotechnology company developing innovative therapeutics based on its gene-silencing technology, DNA-directed RNA interference (ddRNAi), is pleased to announce it has initiated a new site for its ongoing Phase 1/2a TT-034 trial at the Methodist Health System Clinical Research Institute in Dallas, Texas.
A study has shown a potential link between pregnancy-related anxiety and how a baby's brains respond to sad speech.
University of Georgia research has provided new clues on surviving to be 100 years old, finding that how we feel about ourselves and our ability to adapt to an accumulation of challenging life experiences may be as or more important than health factors.
› Verified 1 days ago
Carol E Rosenstiel, OD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 18th St S Ste 200, Birmingham, AL 35233 Phone: 205-325-8620 | |
Alex J Wright, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1720 University Blvd, Birmingham, AL 35233 Phone: 205-325-8100 Fax: 205-325-8547 | |
Elmar M Lawaczeck, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1009 Montgomery Hwy, Suite 200, Birmingham, AL 35216 Phone: 205-397-9400 Fax: 205-397-9455 | |
Matthew Henry Oltmanns, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2208 University Blvd Ste 101, Birmingham, AL 35233 Phone: 205-933-2625 Fax: 205-558-2553 | |
Harold Augustus Helms, MD, PHD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 23rd St S, Ste 100, Birmingham, AL 35205 Phone: 205-933-2020 Fax: 205-933-0908 | |
Krupa Hasmukh Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233 Phone: 205-325-8620 | |
William Charles Gambla, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233 Phone: 205-996-8660 |